News

Tufts Health Plan, Harvard Pilgrim owner to limit coverage of weight-loss drugs
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...
Peninsula biotech lands potential $2.2 billion deal with big player in GLP-1 weight-loss drugs
Want an oral GLP-1 drug? This Peninsula company just landed a big deal to do it. See how the deal is also a potentially ...
Science Media Centre31m
expert reaction to systematic review and meta- analysis on GLP-1 receptor agonists and mental health
A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...
Get The Gloss11m
How to stay healthy on weight loss jabs: nutrition and skin tips from our experts
Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...
Study reveals distinct mechanisms of action of tirzepatide and semaglutide
New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...
Trump reveals mystery friend taking 'fat shot' called him and is 'very concerned' about being named
Donald Trump says he spoke with his friend after he used a story about him buying the 'fat drug shot' overseas at a ...
TAG24 on MSN12m
Study: Wegovy cuts heart disease risk even before people shed weight
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...